Back Translation in Clinical Trials: When Is It Required and How Does It Work?
Back translation in clinical trials is an additional quality‑assurance step that helps to ensure that the translated content conveys the same meaning, safety implications, and regulatory intent as the original. This is especially essential in high‑risk, patient‑facing...
EMA QRD Template: Compliance Guide for SmPC and PIL Submissions
If you work in pharmaceutical regulatory affairs or translation, you have almost certainly encountered the EMA QRD template. According to the European Medicines Agency, human medicines are currently authorised through the EU centralised procedure alone, each requiring...• Officially Certified & Recognised
Guaranteed acceptance by UK Authorities, Home Office, and Courts.
• Trusted by 20,000+ Businesses
Join the industry leaders who trust our translation service with their global voice:
